Literature DB >> 12386935

Pax6; a pleiotropic player in development.

T Ian Simpson1, David J Price.   

Abstract

Pax6 is a transcription factor essential for the development of tissues including the eyes, central nervous system and endocrine glands of vertebrates and invertebrates. It regulates the expression of a broad range of molecules, including transcription factors, cell adhesion and short-range cell-cell signalling molecules, hormones and structural proteins. It has been implicated in a number of key biological processes including cell proliferation, migration, adhesion and signalling both in normal development and in oncogenesis. The mechanisms by which Pax6 regulates its downstream targets likely involve the use of different splice variants and interactions with multiple proteins, allowing it to generate different effects in different cells. Extrapolation to developmental transcription factors in general suggests that variation in the nature of individual factors is likely to contribute to the emergence of differences between tissues. Copyright 2002 Wiley-Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386935     DOI: 10.1002/bies.10174

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  105 in total

1.  Conserved role for the Dachshund protein with Drosophila Pax6 homolog Eyeless in insulin expression.

Authors:  Naoki Okamoto; Yuka Nishimori; Takashi Nishimura
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  GWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern development.

Authors:  Mats Larsson; David L Duffy; Gu Zhu; Jimmy Z Liu; Stuart Macgregor; Allan F McRae; Margaret J Wright; Richard A Sturm; David A Mackey; Grant W Montgomery; Nicholas G Martin; Sarah E Medland
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

3.  The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.

Authors:  Mausam Ghosh; Meredith Lane; Elizabeth Krizman; Rita Sattler; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurochem       Date:  2015-11-24       Impact factor: 5.372

4.  Selective requirement of Pax6, but not Emx2, in the specification and development of several nuclei of the amygdaloid complex.

Authors:  Shubha Tole; Ryan Remedios; Bhaskar Saha; Anastassia Stoykova
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

5.  Transdifferentiation of corneal epithelium into epidermis occurs by means of a multistep process triggered by dermal developmental signals.

Authors:  David J Pearton; Ying Yang; Danielle Dhouailly
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  Crystallization and preliminary X-ray analysis of the Pax6 paired domain bound to the Pax6 gene enhancer.

Authors:  Makoto Ito; Takuji Oyama; Kenji Okazaki; Kosuke Morikawa
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-10-25

7.  Genetic analysis of the Caenorhabditis elegans pax-6 locus: roles of paired domain-containing and nonpaired domain-containing isoforms.

Authors:  Hediye Nese Cinar; Andrew D Chisholm
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

8.  Can Valproic Acid Regulate Neurogenesis from Nestin+ Cells in the Adult Midbrain?

Authors:  Parisa Farzanehfar; Malcolm K Horne; Tim D Aumann
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

Review 9.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

10.  PAX6 maintains β cell identity by repressing genes of alternative islet cell types.

Authors:  Avital Swisa; Dana Avrahami; Noa Eden; Jia Zhang; Eseye Feleke; Tehila Dahan; Yamit Cohen-Tayar; Miri Stolovich-Rain; Klaus H Kaestner; Benjamin Glaser; Ruth Ashery-Padan; Yuval Dor
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.